These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 22206630)

  • 1. Further assessment to determine the additive effect of botulinum toxin type A on an upper extremity exercise program to enhance function among individuals with chronic stroke but extensor capability.
    Wolf SL; Milton SB; Reiss A; Easley KA; Shenvi NV; Clark PC
    Arch Phys Med Rehabil; 2012 Apr; 93(4):578-87. PubMed ID: 22206630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary assessment of the benefits of the addition of botulinum toxin a to a conventional therapy program on the function of people with longstanding stroke.
    Meythaler JM; Vogtle L; Brunner RC
    Arch Phys Med Rehabil; 2009 Sep; 90(9):1453-61. PubMed ID: 19735771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin a, evidence-based exercise therapy, and constraint-induced movement therapy for upper-limb hemiparesis attributable to stroke: a preliminary study.
    Levy CE; Giuffrida C; Richards L; Wu S; Davis S; Nadeau SE
    Am J Phys Med Rehabil; 2007 Sep; 86(9):696-706. PubMed ID: 17709993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
    Pennati GV; Da Re C; Messineo I; Bonaiuti D
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):381-7. PubMed ID: 25358636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of botulinum toxin type A and repetitive transcranial magnetic stimulation with intensive motor training immediately after injection in a patient with chronic stroke: A case report.
    Hirakawa Y; Koyama S; Tanabe S; Takeda K; Ueda T; Motoya I; Sakurai H; Kanada Y; Kawamura N; Kawamura M; Nagata J; Kanno T
    J Hand Ther; 2019; 32(4):519-524. PubMed ID: 30025843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
    Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Davies L; McCrory P; Hughes A
    J Rehabil Med; 2010 Jan; 42(1):81-9. PubMed ID: 20111849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
    Sun SF; Hsu CW; Sun HP; Hwang CW; Yang CL; Wang JL
    Neurorehabil Neural Repair; 2010 Jan; 24(1):34-41. PubMed ID: 19729582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of coupling repetitive transcranial magnetic stimulation and physical therapy to reduce upper-limb spasticity in patients with stroke: a randomized controlled trial.
    Barros Galvão SC; Borba Costa dos Santos R; Borba dos Santos P; Cabral ME; Monte-Silva K
    Arch Phys Med Rehabil; 2014 Feb; 95(2):222-9. PubMed ID: 24239881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course analysis of the effects of botulinum toxin type a on elbow spasticity based on biomechanic and electromyographic parameters.
    Lee HM; Chen JJ; Wu YN; Wang YL; Huang SC; Piotrkiewicz M
    Arch Phys Med Rehabil; 2008 Apr; 89(4):692-9. PubMed ID: 18374000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection.
    Hurvitz EA; Conti GE; Brown SH
    Arch Phys Med Rehabil; 2003 Mar; 84(3):444-54. PubMed ID: 12638115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke.
    Santamato A; Panza F; Filoni S; Ranieri M; Solfrizzi V; Frisardi V; Dellomonaco A; Amoruso MT; Amoruso L; Kehoe PG; Megna M; Fiore P
    Brain Inj; 2010; 24(9):1108-12. PubMed ID: 20569045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of modified constraint-induced movement therapy and intensive conventional therapy with a botulinum-a toxin injection on upper limb motor function recovery in patients with stroke.
    Nasb M; Li Z; S A Youssef A; Dayoub L; Chen H
    Libyan J Med; 2019 Dec; 14(1):1609304. PubMed ID: 31032717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapeutic application of botulinum toxin type A, low-frequency rTMS, and intensive occupational therapy for post-stroke spastic upper limb hemiparesis.
    Kakuda W; Abo M; Momosaki R; Yokoi A; Fukuda A; Ito H; Tominaga A; Umemori T; Kameda Y
    Eur J Phys Rehabil Med; 2012 Mar; 48(1):47-55. PubMed ID: 22071503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
    Marciniak CM; Harvey RL; Gagnon CM; Duraski SA; Denby FA; McCarty S; Bravi LA; Polo KM; Fierstein KM
    Am J Phys Med Rehabil; 2012 Dec; 91(12):1007-19. PubMed ID: 23064478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
    J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on decreasing upper-limb poststroke muscle tone using transcranial direct current stimulation: a randomized sham-controlled study.
    Wu D; Qian L; Zorowitz RD; Zhang L; Qu Y; Yuan Y
    Arch Phys Med Rehabil; 2013 Jan; 94(1):1-8. PubMed ID: 22878231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques.
    Picelli A; Lobba D; Midiri A; Prandi P; Melotti C; Baldessarelli S; Smania N
    Clin Rehabil; 2014 Mar; 28(3):232-42. PubMed ID: 23945164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.